Phase Protective Flow Orders for Sequencing Dephasing

Resolve Bottlenecks,
Find Innovative Solutions
Generate Solutions

Solution Overview

Problem

Traditional sequencing-by-synthesis methodologies face challenges with dephasing, leading to signal loss and reduced base call accuracy, limiting the maximum read length in high-throughput sequencing.

Innovation Solution

The implementation of phase protective flow orders and the use of sequencing solutions with specific combinations of nucleotide types, including reversible terminators, to synchronize nucleotide incorporation and detection, thereby reducing dephasing and improving accuracy.

Engineering Contradictions & Design Principles

VSEngineering Contradiction Analysis

1Productivity

If traditional sequencing-by-synthesis methodologies are used with serial incorporation and detection of labeled nucleotide analogues, then high-throughput sequencing is achieved, but dephasing occurs leading to signal loss and reduced base call accuracy

Engineering Contradiction:
Improvesequencing throughputVSAvoidbase call accuracy
Core Design Contradiction:
ProductivityVSMeasurement precision

Solution Approach 1:

The patent segments the nucleotide incorporation process into distinct cycles, where each cycle incorporates a specific nucleotide type (A, C, G, or T) followed by detection and cleavage. This segmentation prevents simultaneous incorporation of multiple nucleotides, eliminating dephasing and maintaining synchronization across all clusters, thereby improving base call accuracy while preserving high throughput.

Inventive Principle:
Principle #1Segmentation

Solution Approach 2:

The patent implements periodic action by repeating the sequence of nucleotide incorporation, detection, and cleavage in cyclic fashion. Each cycle processes all clusters simultaneously with the same nucleotide type, creating a rhythmic pattern that maintains synchronization. This periodic process allows high-throughput sequencing while preventing dephasing, as every cluster progresses through the same periodic steps at the same rate.

Inventive Principle:
Principle #19Periodic action

2Reliability

If cleavable fluorescent nucleotide reversible terminator chemistry is used, then nucleotide incorporation is controlled and detected, but dephasing leads to signal loss and lowered base call accuracy

Engineering Contradiction:
Improvenucleotide incorporation controlVSAvoidbase call accuracy
Core Design Contradiction:
ReliabilityVSMeasurement precision

Solution Approach 1:

The patent incorporates feedback mechanisms where the detection step immediately follows nucleotide incorporation, and the cleavage step immediately removes the reversible terminator. This rapid feedback loop ensures that incorporation is confirmed and controlled before the next cycle begins, preventing dephasing. The feedback mechanism maintains synchronization across all clusters, improving base call accuracy while preserving reliable nucleotide incorporation control.

Inventive Principle:
Principle #23Feedback

3Productivity

If many polynucleotides are confined to discrete regions and synchronized in nucleotide incorporation, then high-throughput sequencing is enabled, but some strands extend at different rates causing dephasing

Engineering Contradiction:
Improvesequencing throughputVSAvoidsynchronization of nucleotide incorporation
Core Design Contradiction:
ProductivityVSStability of the object's composition

Solution Approach 1:

The patent introduces dynamic control through the reversible terminator chemistry, which allows the polymerase to pause incorporation at controlled intervals. This dynamic mechanism adjusts the incorporation rate to match the slowest strand in each cluster, ensuring all strands remain synchronized. The dynamic adjustment prevents dephasing while maintaining the ability to process many clusters simultaneously, preserving high throughput.

Inventive Principle:
Principle #15Dynamics

4Productivity

If dephasing occurs during SBS, then sequencing cycles can be completed, but signal loss occurs and maximum read length is restricted

Engineering Contradiction:
Improvesequencing cycle completionVSAvoidread length
Core Design Contradiction:
ProductivityVSLength of moving object

Solution Approach 1:

The patent applies preliminary action by performing detection and cleavage steps immediately after nucleotide incorporation, before the next incorporation cycle begins. This preliminary completion of the detection and cleavage processes ensures that all clusters are ready for the next cycle simultaneously, preventing dephasing. By completing these steps in advance, the system maintains synchronization over many cycles, enabling longer read lengths while preserving productivity.

Inventive Principle:
Principle #10Preliminary action

Applied Scientific Principles

This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.

Function Achieved in This Case

This approach enhances sequencing fidelity and accuracy, allowing for longer read lengths by minimizing signal loss and maintaining synchronization of nucleotide incorporation across clusters.

Implementation Method 1

each of the four nucleotide types (dA, dC, dG, dT, and/or dU) is modified by attaching a unique cleavable fluorophore to the specific location of the nucleobase and capping the 3′—OH group of the nucleotide sugar with a small reversible moiety (also referred to herein as a reversible terminator) so that they are still recognized by DNA polymerase as substrates. The reversible terminator temporarily halts the polymerase reaction after nucleotide incorporation while the fluorophore signal is detected.

Methodology Applied
Scientific EffectReversible terminator mechanism:

Implementation Method 2

attaching a unique cleavable fluorophore to the specific location of the nucleobase... while the fluorophore signal is detected

Methodology Applied
Scientific EffectFluorescence detection: Fluorescence

Implementation Method 3

contacting the nucleic acid template with a sequencing solution in the presence of a polymerase... detecting a characteristic signature indicating that the nucleotide has been incorporated into the sequencing primer

Methodology Applied
Scientific EffectPolymerase catalysis: Enzyme

Data Source

PatentUS20230265501A1Phase protective reagent flow ordering
Publication Date: 2023.08.24 SINGULAR GENOMICS SYSTEMS INC
  • US20230265501A1 patent drawing
  • US20230265501A1 patent drawing
  • US20230265501A1 patent drawing

AI summary

Disclosed herein, inter alia, are phase protective reagent flow orders and methods useful for improving sequencing efficiency.